Therefore, these polymorphisms may be significant predictors of clinical outcome globally.
← all excerpts
Polymorphisms of <i>GSTP1</i>, <i>ERCC2</i> and <i>TS</i>-3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients.
1
—
—